Antibodies
23 May 2007
Lpath Demonstrates ‘First-in-Class’ AMD Results With Its Lead Drug Candidate, Sphingomab(TM)22 May 2007
Elan and Wyeth to Initiate Phase 3 Clinical Trial of Bapineuzumab (AAB-001) in Alzheimer’s Disease5 May 2007
Abbott’s Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis StudyNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports